US House Veterans' Affairs health subcommittee to hold hearing on psychedelic-assisted therapies for veterans
Congress To Hold Hearing Focused On Psychedelic Therapy For Military Veterans This Week
The House Veterans' Affairs Subcommittee on Health will hold a Wednesday hearing titled "Psychedelic-Assisted Therapies for Veterans: The Path Forward," with VA officials, medical professionals and researchers testifying. A VA official's written testimony says the department is conducting 21 active clinical studies on psychedelics, including a trial announced in August on psilocybin for veterans with treatment-resistant depressiontreatment-resistant depressionDepression that has not improved enough after adequate courses of at least two antidepressant treatments.Open the glossary.
Key facts
- Kind of item
- Guidance and consultations
- Compounds
- Psilocybin, MDMA, Ibogaine
- Regulator
- FDA (United States)
- Jurisdiction
- United States
- Source
- Marijuana Moment (psychedelics policy only) (marijuanamoment.net)
- Published
- Original
- Read it at marijuanamoment.net
How this summary was made
The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method
Source: Marijuana Moment (psychedelics policy only) · marijuanamoment.net
Connected to
- Kind of item
- Guidance and consultations
- Compounds
- PsilocybinMDMAIbogaine
- Regulator
- FDA (United States)
- Jurisdiction
- United States